[#item_full_content]
LONDON & SAN FRANCISCO–(BUSINESS WIRE)–Today, Latent Labs launches Latent-Y, its lab-validated drug design agent, to researchers worldwide through the Latent Labs Platform. Any approved researcher can now access Latent-Y for free, with a daily design quota included at no cost. For larger campaigns, researchers can purchase additional design credits on demand. Latent-Y is an AI agent for drug design. It takes a therapeutic goal, specified in written language or as a scientific publication, and